Shared decision making in mental health: current status Several arguments suggest the importance

of shared decision making in mental health. First and foremost, effective mental health care should be person-centered .8,9 As is true with other long-term illnesses,10,11 empowering people to be knowledgeable and active in managing their own mental illnesses is critical.12 Decisions related to chronic illnesses differ from acute-care decisions in several ways: for example, there are many opportunities to make and revisit the decisions, and the patient must take much greater responsibility in carrying out Inhibitors,research,lifescience,medical decisions daily.10 Because of personal values and subjective responses, patients themselves can best evaluate tradeoffs in efficacy and side effects.13-14 In mental health, shared decision making enhances the working relationship needed to optimize long-term outcomes.15 For example, learning to manage one’s illness Inhibitors,research,lifescience,medical with medications involves a dynamic, longitudinal process that encompasses resolving decisional conflicts, conducting experiments, balancing positive and negative effects, and making changes. A close working alliance Inhibitors,research,lifescience,medical between practitioner and client is the sine qua non of success. In addition to these practical concerns,

others have made ethical and legal arguments for shared decision making. Autonomy – the right to make decisions regarding one’s body – has long been a fundamental principle of Western medical ethics.16 Recognizing the Brefeldin A 20350-15-6 importance of autonomy,

the legal standard for medical care is shifting from informed consent to informed choice among reasonable alternatives.17 Most mental health patients express a desire to participate in making decisions regarding medications and hospitalizations. 18,21 Nevertheless, Inhibitors,research,lifescience,medical shared decision making is not prominent in widely disseminated psychiatric medication algorithms22 and not usually practiced in daily medication management.15 Patients with severe and persistent mental illnesses report that their perceived role Inhibitors,research,lifescience,medical in making medical decisions is usually passive.1,21,23 Further, many psychiatrists consistently report that shared decision making is not applicable to decisions regarding medications and hospitalizations due to patients’ decisional incapacity.24,25 At the same time, the evidence in support of shared decision GSK-3 making in mental health is expanding rapidly. First, nearly all psychiatric patients, even the great majority of those with the most severe disorders such as schizophrenia, are capable of understanding treatment choices and making rational decisions.26,28 Like many other patients with inhibitor order us limited education, learning disorders, or other disadvantages, some require repetition of information or multimodal sources of information.29 Also, some psychiatric patients experience temporary decisional incapacity, such as during psychotic episodes, and may elect to establish psychiatric advanced directives to cover such periods of decisional incapacity.